Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetter

Abstract

The novel coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is currently the biggest threat to the public health and an enormous challenge to the healthcare systems across the world.
Original languageEnglish
JournalJournal of Medical Virology
Early online date9 Sep 2020
DOIs
Publication statusE-pub ahead of print - 9 Sep 2020

Fingerprint Dive into the research topics of 'Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis'. Together they form a unique fingerprint.

  • Cite this